Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

Pharma-Bio Serv (PBSV) Loans and Notes Receivables (2018 - 2020)

Pharma-Bio Serv (PBSV) has disclosed Loans and Notes Receivables for 3 consecutive years, with $1.2 million as the latest value for Q4 2020.

  • For the quarter ending Q4 2020, Loans and Notes Receivables changed 0.0% year-over-year to $1.2 million, compared with a TTM value of $1.2 million through Oct 2020, changed 0.0%, and an annual FY2020 reading of $1.2 million, changed 0.0% over the prior year.
  • Loans and Notes Receivables was $1.2 million for Q4 2020 at Pharma-Bio Serv, roughly flat from $1.2 million in the prior quarter.
  • Across five years, Loans and Notes Receivables topped out at $1.8 million in Q4 2018 and bottomed at $1.2 million in Q4 2019.
  • Average Loans and Notes Receivables over 3 years is $1.4 million, with a median of $1.2 million recorded in 2019.
  • The sharpest move saw Loans and Notes Receivables decreased 28.57% in 2019, then changed 0.0% in 2020.
  • Year by year, Loans and Notes Receivables stood at $1.8 million in 2018, then fell by 28.57% to $1.2 million in 2019, then changed by 0.0% to $1.2 million in 2020.
  • Business Quant data shows Loans and Notes Receivables for PBSV at $1.2 million in Q4 2020, $1.2 million in Q4 2019, and $1.8 million in Q4 2018.